Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatopulmonary syndrome.

C Müller1, P Schenk

  • 1Klinische Abteilung für Gastroenterologie und Hepatologie, Universitätsklinik für Innere Medizin IV, Vienna, Austria. christian.muller@akh-wien.ac.at

Wiener Klinische Wochenschrift
|July 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Psychiatrists who took shelter in French-speaking Switzerland from 1933-1945].

Revue medicale de la Suisse romande·1992
Same author

Systemic levels of tumor necrosis factor alpha during hemodialysis with cellulosic membranes: no effect of the sterilization procedure.

Artificial organs·1992
Same author

Quantitative assessment of urinary protein and enzyme excretion--a diagnostic programme for the detection of renal involvement in type I diabetes mellitus.

Scandinavian journal of clinical and laboratory investigation·1992
Same author

[Immunohistochemical findings in otosclerotic lesions].

HNO·1992
Same author

Peri-operative liver graft function: monitoring using the relationship between blood glucose and oxygen consumption during anaesthesia.

Anaesthesia·1992
Same author

Variables associated with the assessment of systemic tumor necrosis factor alpha levels during hemodialysis.

The International journal of artificial organs·1992
Same journal

[Vaccination of immunocompromised individuals: Expert opinion - update 2026].

Wiener klinische Wochenschrift·2026
Same journal

Systematic review of clinical evidence for Kneipp medicine.

Wiener klinische Wochenschrift·2026
Same journal

Pelvic resections in primary sarcomas : Surgical outcomes and survival analysis of 75 patients.

Wiener klinische Wochenschrift·2026
Same journal

Jungmediziner*innen am Start: 11. Workshop für den medizinischen Nachwuchs.

Wiener klinische Wochenschrift·2026
Same journal

Stellungnahme der ÖGP zur geplanten Gesetzesnovelle zum Nichtraucherschutzgesetz.

Wiener klinische Wochenschrift·2026
Same journal

MUW researcher of the month: Dr. Moritz Schaefer.

Wiener klinische Wochenschrift·2026
See all related articles

Hepatopulmonary syndrome (HPS) in liver cirrhosis causes low oxygen levels due to dilated lung vessels. Liver transplantation can significantly improve lung function in select patients.

Area of Science:

  • Pulmonology
  • Gastroenterology
  • Vascular Medicine

Background:

  • Hepatopulmonary syndrome (HPS) is a serious complication of liver cirrhosis.
  • It presents with liver disease, hypoxemia, and intrapulmonary vascular dilatation.
  • Pulmonary function is impaired by dilated precapillary vessels, affecting gas exchange.

Purpose of the Study:

  • To describe the characteristics and diagnostic criteria of hepatopulmonary syndrome.
  • To outline current management strategies and potential treatments for HPS.

Main Methods:

  • Diagnosis relies on arterial blood gas measurements (PaO2) under room air and 100% oxygen.
  • Intravenous agitated saline administration detects microbubble passage through lung capillaries.
  • Exclusion of other cardiac or pulmonary diseases is crucial.

Related Experiment Videos

Main Results:

  • Intrapulmonary vascular dilatation is the key structural finding in HPS.
  • Impaired diffusion-perfusion and ventilation-perfusion mismatch result from vascular changes.
  • Most patients' primary morbidity stems from liver disease, not pulmonary issues.

Conclusions:

  • HPS diagnosis involves specific gas exchange abnormalities and vascular findings.
  • Medical therapies lack proven benefit; oxygen may alleviate dyspnea.
  • Liver transplantation or embolization offers significant pulmonary improvement in eligible patients.